BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 28642592)

  • 1. Integrative network analysis identifies novel drivers of pathogenesis and progression in newly diagnosed multiple myeloma.
    Laganà A; Perumal D; Melnekoff D; Readhead B; Kidd BA; Leshchenko V; Kuo PY; Keats J; DeRome M; Yesil J; Auclair D; Lonial S; Chari A; Cho HJ; Barlogie B; Jagannath S; Dudley JT; Parekh S
    Leukemia; 2018 Jan; 32(1):120-130. PubMed ID: 28642592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Key Genes and Pathways in Myeloma side population cells by Bioinformatics Analysis.
    Yang Q; Li K; Li X; Liu J
    Int J Med Sci; 2020; 17(14):2063-2076. PubMed ID: 32922167
    [No Abstract]   [Full Text] [Related]  

  • 3. Using MMRFBiolinks R-Package for Discovering Prognostic Markers in Multiple Myeloma.
    Settino M; Cannataro M
    Methods Mol Biol; 2022; 2401():289-314. PubMed ID: 34902136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic profiling of multiple myeloma: New insights and modern technologies.
    Hultcrantz M; Yellapantula V; Rustad EH
    Best Pract Res Clin Haematol; 2020 Mar; 33(1):101153. PubMed ID: 32139018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of esterase gene expression in multiple myeloma.
    Kumari R; Majumder MM; Lievonen J; Silvennoinen R; Anttila P; Nupponen NN; Lehmann F; Heckman CA
    Br J Cancer; 2021 Apr; 124(8):1428-1436. PubMed ID: 33531688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MMRFBiolinks: an R-package for integrating and analyzing MMRF-CoMMpass data.
    Settino M; Cannataro M
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33821961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets.
    Hideshima T; Mitsiades C; Tonon G; Richardson PG; Anderson KC
    Nat Rev Cancer; 2007 Aug; 7(8):585-98. PubMed ID: 17646864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights from the gene expression profiling of multiple myeloma.
    Claudio JO; Masih-Khan E; Stewart AK
    Curr Hematol Rep; 2004 Jan; 3(1):67-73. PubMed ID: 14695854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next Generation Sequencing-based Validation of the Revised International Staging System for Multiple Myeloma: An Analysis of the MMRF CoMMpass Study.
    Goldsmith SR; Fiala MA; Dukeman J; Ghobadi A; Stockerl-Goldstein K; Schroeder MA; Tomasson M; Wildes TM; Vij R
    Clin Lymphoma Myeloma Leuk; 2019 May; 19(5):285-289. PubMed ID: 30792096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple Myeloma Genomics: A Systematic Review.
    Weaver CJ; Tariman JD
    Semin Oncol Nurs; 2017 Aug; 33(3):237-253. PubMed ID: 28729121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis.
    Walker BA; Mavrommatis K; Wardell CP; Ashby TC; Bauer M; Davies F; Rosenthal A; Wang H; Qu P; Hoering A; Samur M; Towfic F; Ortiz M; Flynt E; Yu Z; Yang Z; Rozelle D; Obenauer J; Trotter M; Auclair D; Keats J; Bolli N; Fulciniti M; Szalat R; Moreau P; Durie B; Stewart AK; Goldschmidt H; Raab MS; Einsele H; Sonneveld P; San Miguel J; Lonial S; Jackson GH; Anderson KC; Avet-Loiseau H; Munshi N; Thakurta A; Morgan G
    Leukemia; 2019 Jan; 33(1):159-170. PubMed ID: 29967379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups.
    Bolli N; Biancon G; Moarii M; Gimondi S; Li Y; de Philippis C; Maura F; Sathiaseelan V; Tai YT; Mudie L; O'Meara S; Raine K; Teague JW; Butler AP; Carniti C; Gerstung M; Bagratuni T; Kastritis E; Dimopoulos M; Corradini P; Anderson KC; Moreau P; Minvielle S; Campbell PJ; Papaemmanuil E; Avet-Loiseau H; Munshi NC
    Leukemia; 2018 Dec; 32(12):2604-2616. PubMed ID: 29789651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular signatures of multiple myeloma progression through single cell RNA-Seq.
    Jang JS; Li Y; Mitra AK; Bi L; Abyzov A; van Wijnen AJ; Baughn LB; Van Ness B; Rajkumar V; Kumar S; Jen J
    Blood Cancer J; 2019 Jan; 9(1):2. PubMed ID: 30607001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an RNA sequencing-based prognostic gene signature in multiple myeloma.
    Zamani-Ahmadmahmudi M; Nassiri SM; Soltaninezhad F
    Br J Haematol; 2021 Jan; 192(2):310-321. PubMed ID: 32410217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular profiling of multiple myeloma: from gene expression analysis to next-generation sequencing.
    Agnelli L; Tassone P; Neri A
    Expert Opin Biol Ther; 2013 Jun; 13 Suppl 1():S55-68. PubMed ID: 23614397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromatin Accessibility Identifies Regulatory Elements Predictive of Gene Expression and Disease Outcome in Multiple Myeloma.
    Barwick BG; Gupta VA; Matulis SM; Patton JC; Powell DR; Gu Y; Jaye DL; Conneely KN; Lin YC; Hofmeister CC; Nooka AK; Keats JJ; Lonial S; Vertino PM; Boise LH
    Clin Cancer Res; 2021 Jun; 27(11):3178-3189. PubMed ID: 33731366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative multi-omics identifies high risk multiple myeloma subgroup associated with significant DNA loss and dysregulated DNA repair and cell cycle pathways.
    Ortiz-Estévez M; Towfic F; Flynt E; Stong N; Jang IS; Wang K; Trotter MWB; Thakurta A
    BMC Med Genomics; 2021 Dec; 14(1):295. PubMed ID: 34922559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative analysis of DNA copy number, DNA methylation and gene expression in multiple myeloma reveals alterations related to relapse.
    Krzeminski P; Corchete LA; García JL; López-Corral L; Fermiñán E; García EM; Martín AA; Hernández-Rivas JM; García-Sanz R; San Miguel JF; Gutiérrez NC
    Oncotarget; 2016 Dec; 7(49):80664-80679. PubMed ID: 27811368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple myeloma-derived Jagged ligands increases autocrine and paracrine interleukin-6 expression in bone marrow niche.
    Colombo M; Galletti S; Bulfamante G; Falleni M; Tosi D; Todoerti K; Lazzari E; Crews LA; Jamieson CH; Ravaioli S; Baccianti F; Garavelli S; Platonova N; Neri A; Chiaramonte R
    Oncotarget; 2016 Aug; 7(35):56013-56029. PubMed ID: 27463014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-cell RNA-seq reveals clonal diversity and prognostic genes of relapsed multiple myeloma.
    He H; Li Z; Lu J; Qiang W; Jiang S; Xu Y; Fu W; Zhai X; Zhou L; Qian M; Du J
    Clin Transl Med; 2022 Mar; 12(3):e757. PubMed ID: 35297204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.